title: Azadirachta indica exhibits chemopreventive action against hepatic cancer: Studies on associated histopathological and ultrastructural changes.
abstract: The present study was designed to evaluate the anticarcinogenic potential of Azadirachta indica against N-nitrosodiethylamine (NDEA)-induced hepatocarcinogenesis. Further, the associated histopathological and ultrastructural changes were also analyzed. Hepatic cancer model was developed by the intraperitoneal administration of NDEA to mice at weekly intervals, in successive increasing doses, for a period of 8 weeks. Aqueous A. indica leaf extract (AAILE) was administered orally at a dosage of 100 μg/g body weight thrice a week till termination of the study. A relationship between histopathological grading and chemopreventive effect of A. indica had been established at various stages of carcinogenesis. Anticancer activity of A. indica was evaluated in terms of tumor incidence, tumor multiplicity, and survival rate. A significant reduction in tumor incidence (33%), tumor multiplicity (42%), and increase in survival (34%) was observed upon administration of AAILE to NDEA-abused mice. Transmission and scanning electron microscopic investigations showed severe alterations in organelle organization, cellular arrangement, degree of differentiation, cellular metabolism, and morphology of the hepatocytes. These changes appeared to be distinctly delayed upon AAILE supplementation. The results suggest A. indica may have anticancer potential against NDEA-induced hepatic cancer.
authors: Department of Biophysics, Basic Medical Sciences Block, Panjab University, Chandigarh 160014, India.
authors: Sanjay
authors: S
authors: Bharati
authors: Praveen
authors: P
authors: Rishi
authors: Ashwani
authors: A
authors: Koul
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000302:isolation & purification; D031601:Azadirachta / Q000737:chemistry*; D002273:Carcinogens / Q000008:administration & dosage; D018890:Chemoprevention / Q000379:methods*; D004052:Diethylnitrosamine / Q000008:administration & dosage; D004195:Disease Models, Animal; D006651:Histocytochemistry; D015994:Incidence; D008099:Liver / Q000473:pathology; D008113:Liver Neoplasms / Q000139:chemically induced / Q000473:pathology / Q000517:prevention & control*; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008853:Microscopy; D015388:Organelles / Q000648:ultrastructure; D010936:Plant Extracts / Q000008:administration & dosage* / Q000302:isolation & purification; D016019:Survival Analysis
chemical_list: D000970:Antineoplastic Agents; D002273:Carcinogens; D010936:Plant Extracts; D004052:Diethylnitrosamine